Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 321.00
Ask: 322.00
Change: -1.00 (-0.31%)
Spread: 1.00 (0.312%)
Open: 322.00
High: 322.00
Low: 320.00
Prev. Close: 321.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Project Helix

19 Mar 2019 15:16

RNS Number : 3441T
Bank of Cyprus Holdings PLC
19 March 2019
 

Announcement

 

Update on Project Helix - Agreement for the sale of a portfolio of non-performing loans

 

 

Nicosia, 19 March 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

 

Further to the announcement of 28 August 20181 in relation to the agreement for the sale of a portfolio of non-performing loans, known as "Project Helix", or the "Transaction", Bank of Cyprus Holdings Public Limited Company ("BOCH" and, together with its subsidiaries, the "Group") announces that it has received approval from the ECB for the Significant Risk Transfer ("SRT") benefit from the Transaction.

This is an important step towards completion of the Transaction, which remains subject to various outstanding conditions precedent1. Completion is currently expected to occur in early 2Q2019.

As previously reported, the Transaction reduces the Group's non-performing exposures (NPEs) by €2.7 bn and improves the NPE ratio from 47% to 36%3. The NPE provisioning coverage ratio pro forma for the Transaction stands at 47%3.

On completion, the derecognition of the Helix portfolio is expected to have a positive impact on the capital ratios of 160 basis points2, resulting from the release of risk weighted assets.

As at 31 December 2018, as previously reported, the Group's phased-in CET1 ratio and Total capital ratio, pro forma for both DTC2 and Helix, stood at 15.4% and 18.3% respectively.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

[1] Further to the announcement of 28 August 2018 and updates provided with the publication of the Group financial results for the nine months ended 30 September 2018 and the preliminary Group financial results for the year ended 31 December 2018

2 Refer to slide 36 of the presentation for the preliminary Group financial results for the year ended 31 December 2018 published on 4 March 2019

3 Based on the preliminary Group financial results for the year ended 31 December 2018

4 DTC refers to the amendments in the legislation adopted by the Cyprus Parliament on 1 March 2019 and was published on the Official Gazette of the Republic on 15 March 2019

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 112 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,146 staff worldwide. At 31 December 2018, the Group's Total Assets amounted to €22.1 bn and Total Equity was €2.4 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURLLFLEVVIALIA
Date   Source Headline
5th Feb 202112:53 pmRNSResult of Meeting
4th Feb 20214:40 pmRNSSecond Price Monitoring Extn
4th Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20212:15 pmRNSCurrency change on the London Stock Exchange
20th Jan 20218:12 amRNSTR-1 Notification of Holding -Carval
19th Jan 20219:03 amRNSTR-1 Notification of Holding -Carval
18th Jan 20217:00 amRNSAgreement for sale of portf. of Non Perform. Loans
13th Jan 20216:09 pmRNSEGM Circular
13th Jan 20215:56 pmRNSNotice of EGM and Publication of Circular
13th Jan 20218:08 amRNSTR-1 Notification Form -Eaton Vance Amended
11th Jan 20218:25 amRNSTR1 Notification Form - Eaton Vance
4th Jan 20217:34 amRNSHolding(s) in Company
11th Dec 20205:22 pmRNSEU-wide Transparency Exercise 2020
27th Nov 20207:03 amRNSDoc re. (9M2020 Investor Presentation)
27th Nov 20207:00 amRNSGroup Financial Results for 9M2020
26th Nov 20208:12 amRNSTR-1 Notification of Major Holdings- Senvest
17th Nov 202010:12 amEQSBank of Cyprus Holdings PLC: Date of announcement of 9M2020 Financial Results
12th Nov 20209:01 amRNSTR-1 Notification of Holding -Caius
28th Sep 20207:00 amRNSChanges in the Board Composition
1st Sep 20204:35 pmRNSPrice Monitoring Extension
28th Aug 202010:51 amRNSInterim Financial Report 2020 - Part 3
28th Aug 202010:50 amRNSInterim Financial Report 2020 - Part 2
28th Aug 202010:50 amRNSInterim Financial Report 2020 - Part 1
28th Aug 20207:05 amRNSDoc re. (1?2020 Investor Presentation)
28th Aug 20207:00 amRNSGroup Financial Results for 1H2020
20th Aug 20206:18 pmRNSDate of Announcement of 1H2020 FR
17th Aug 20209:14 amRNSDate of announcement of 1H2020 FR
3rd Aug 20207:00 amRNSAgreement for sale of a portfolio of NPLs
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20208:56 amRNSTR1 Form -Morgan Stanley
8th Jun 20205:35 pmRNSSpring EU-wide Transparency Exercise 2020
4th Jun 20208:13 amRNSTR-1 Notification - Caius
27th May 20202:23 pmRNSReplacement AGM Resolutions
26th May 20204:41 pmRNSSecond Price Monitoring Extn
26th May 20204:36 pmRNSPrice Monitoring Extension
26th May 20202:14 pmRNSResolutions of the Shareholders AGM
26th May 20202:03 pmRNSDirectorate Change
26th May 20207:04 amRNSDoc re. (1Q2020 Investor Presentation)
26th May 20207:00 amRNS1Q2020 Group Financial Results
14th May 202011:10 amRNSNotice of 1Q2020 Results
30th Apr 20203:25 pmRNSPillar 3 Disclosures for 2019
29th Apr 20209:44 amRNSBOC Annual Financial Report 2019
29th Apr 20209:39 amRNSBOCH Annual Financial Report 2019
29th Apr 20207:02 amRNSDoc re. (FY2019 Investor Presentation)
29th Apr 20207:00 amRNSFY2019 Group Financial Results
24th Apr 20209:29 amRNSNotice of AGM
16th Apr 20209:19 amRNSNotice of Results
15th Apr 20207:47 amRNSTR-1 Standard Form for Morgan Stanley
15th Apr 20207:37 amRNSChanges in the Board Composition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.